StreetInsider.com News Articles

New LifeVantage Research Explores How Protandim® Nrf2 Supports Cellular Defense Against Five Modern Environmental Toxins*

Thu, 29 Oct 2026 16:05:00 -0500

SALT LAKE CITY, Oct. 29, 2026 (GLOBE NEWSWIRE) -- LifeVantage Corporation® (Nasdaq: LFVN) continues to lead the next generation of healthy aging with its latest in vitro research study examining how five modern environmental toxins—pollution, microplastics, ultra-processed foods, hormone disruptors, and pesticides—affect cells and the role Protandim® Nrf2 can play in helping protect against their impact.† These findings further reinforce LifeVantage’s position as a pioneer in nutrigenomics and the science behind its products that ignite the human body’s natural defense systems.

“Modern life exposes people to things they cannot always see or avoid. Our work

New LifeVantage Research Explores How Protandim® Nrf2 Supports Cellular Defense Against Five Modern Environmental Toxins*

Thu, 29 Oct 2026 16:05:00 -0500

“Modern life exposes people to things they cannot always see or avoid. Our work

LifeVantage to Announce First Quarter Fiscal Year 2027 Results on November 9, 2026

Mon, 26 Oct 2026 16:05:00 -0500

SALT LAKE CITY, Oct. 26, 2026 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq:LFVN) a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today announced that it will release financial results for its first quarter ended September 30, 2026, after the stock market closes on Monday, November 9, 2026. The Company will hold a conference call for investors at 2:30 p.m. Mountain Time (4:30 p.m. Eastern Time) that same day.

Investors interested in participating in the live call can dial (877) 704-4453 from the U.S. or international callers

LifeVantage to Announce First Quarter Fiscal Year 2027 Results on November 9, 2026

Mon, 26 Oct 2026 16:05:00 -0500

Investors interested in participating in the live call can dial (877) 704-4453 from the U.S. or international callers

Form SCHEDULE 13G/A Lifevantage Corp Filed by: CAPITAL MANAGEMENT CORP /VA

Thu, 22 Oct 2026 16:36:00 -0500

si-local-file:///var/storage/secattach/20261022/27223199.html

LifeVantage Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Mon, 12 Oct 2026 16:05:00 -0500

SALT LAKE CITY, Oct. 12, 2026 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq: LFVN) (“LifeVantage” or the “Company”) today announced that its Board of Directors granted inducement awards to Terrence Moorehead, the Company’s President and Chief Executive Officer, under the Company’s 2026 New Employee Long-Term Incentive Plan. The awards were granted pursuant to the key executive benefits agreement between the Company and Mr. Moorehead, dated as of April 15, 2026, as an inducement material to Mr. Moorehead’s employment in accordance with Nasdaq Listing Rule 5635(c)(4).

The awards were granted on October 7, 2026 and consist of

LifeVantage Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Mon, 12 Oct 2026 16:05:00 -0500

The awards were granted on October 7, 2026 and consist of

Form 4 Lifevantage Corp For: Oct 07 Filed by: Cunningham Kristen

Fri, 09 Oct 2026 16:13:00 -0500

si-local-file:///var/storage/secattach/20261009/27171658.html

Form 4 Lifevantage Corp For: Oct 07 Filed by: Aure Carl

Fri, 09 Oct 2026 16:09:00 -0500

si-local-file:///var/storage/secattach/20261009/27171610.html

Form 4 Lifevantage Corp For: Oct 07 Filed by: Moorehead Terrence

Fri, 09 Oct 2026 16:05:00 -0500

si-local-file:///var/storage/secattach/20261009/27171540.html

Form 4 Lifevantage Corp For: Oct 01 Filed by: Aure Carl

Mon, 05 Oct 2026 16:13:00 -0500

si-local-file:///var/storage/secattach/20261005/27148913.html

Form 4 Lifevantage Corp For: Oct 01 Filed by: Cunningham Kristen

Mon, 05 Oct 2026 16:13:00 -0500

si-local-file:///var/storage/secattach/20261005/27148912.html

Form 8-K Lifevantage Corp For: Sep 29

Mon, 05 Oct 2026 16:11:00 -0500

si-local-file:///var/storage/secattach/20261005/27148888.html

Form ARS Lifevantage Corp For: Jun 30

Fri, 18 Sep 2026 16:15:00 -0500

si-local-file:///var/storage/secattach/20260918/27080700.html

Form DEFA14A Lifevantage Corp

Fri, 18 Sep 2026 16:10:00 -0500

si-local-file:///var/storage/secattach/20260918/27080635.html

Form DEF 14A Lifevantage Corp For: Nov 05

Fri, 18 Sep 2026 16:05:00 -0500

si-local-file:///var/storage/secattach/20260918/27080542.html

LifeVantage to Participate in the WTR Virtual Insights Conference on Wednesday, September 23, 2026

Fri, 18 Sep 2026 08:00:00 -0500

SALT LAKE CITY, Sept. 18, 2026 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq: LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today announced that Terrence Moorehead, Chief Executive Officer, and Carl Aure, Chief Financial Officer, will participate in the upcoming WTR Virtual Insights Conference on Wednesday, September 23, 2026.

The webcast of the presentation will begin at approximately 1:30 p.m. Eastern Time on Wednesday, September 23, 2026. The event is open access for all investors and interested parties can register through the Company’s Investor Relations

LifeVantage to Participate in the WTR Virtual Insights Conference on Wednesday, September 23, 2026

Fri, 18 Sep 2026 08:00:00 -0500

Form 4 Lifevantage Corp For: Sep 15 Filed by: Lewis Darwin

Thu, 17 Sep 2026 16:05:00 -0500

si-local-file:///var/storage/secattach/20260917/27075826.html

Form 4 Lifevantage Corp For: Sep 10 Filed by: Aure Carl

Mon, 14 Sep 2026 18:56:00 -0500

si-local-file:///var/storage/secattach/20260914/27059666.html

Form 4 Lifevantage Corp For: Sep 10 Filed by: Cunningham Kristen

Mon, 14 Sep 2026 18:56:00 -0500

si-local-file:///var/storage/secattach/20260914/27059665.html

Lifevantage Corporation (LFVN) PT Raised to $6 at Lake Street

Fri, 28 Aug 2026 09:25:03 -0500

Lake Street analyst Ryan M raised the price target on Lifevantage Corporation (NASDAQ: LFVN) to $6.00 (from $5.00) while maintaining a Hold rating.

Lifevantage (LFVN) Misses Q4 EPS by 2c

Thu, 27 Aug 2026 16:06:18 -0500

Lifevantage (NASDAQ: LFVN) reported Q4 EPS of $0.11, $0.02 worse than the analyst estimate of $0.13. Revenue for the quarter came in at $42.37 million versus the consensus estimate of $44.37 million.

For earnings history and earnings-related data on Lifevantage (LFVN) click here.

Form 10-K Lifevantage Corp For: Jun 30

Thu, 27 Aug 2026 16:06:00 -0500

si-local-file:///var/storage/secattach/20260827/26989857.html

Form 10-K Lifevantage Corp For: Jun 30

Thu, 27 Aug 2026 16:06:00 -0500

si-local-file:///var/storage/secattach/20260827/26989857.html